All listed drugs share the same DEA schedule. Which option correctly identifies that schedule?

Prepare for the Montana MPJE. Study with flashcards and multiple-choice questions, each question has hints and explanations. Get ready for your exam!

Multiple Choice

All listed drugs share the same DEA schedule. Which option correctly identifies that schedule?

Explanation:
The key idea is how the DEA classifies drugs by abuse potential and medical use. Opioids are placed in Schedule II because they have a high potential for abuse and dependence, but they also have accepted medical uses for pain relief. That combination of high risk and legitimate use leads to strict controls: prescriptions are tightly regulated (typically requiring written or electronic orders, with limited or no refills) and distribution is closely tracked. If the drugs listed are all opioids, they fit Schedule II because of their potency and risk profile, even though some other drug types with medical use might be placed in lower schedules (which have more lenient prescribing rules). So Schedule II is the label that best captures both their accepted medical utility and their high potential for abuse.

The key idea is how the DEA classifies drugs by abuse potential and medical use. Opioids are placed in Schedule II because they have a high potential for abuse and dependence, but they also have accepted medical uses for pain relief. That combination of high risk and legitimate use leads to strict controls: prescriptions are tightly regulated (typically requiring written or electronic orders, with limited or no refills) and distribution is closely tracked.

If the drugs listed are all opioids, they fit Schedule II because of their potency and risk profile, even though some other drug types with medical use might be placed in lower schedules (which have more lenient prescribing rules). So Schedule II is the label that best captures both their accepted medical utility and their high potential for abuse.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy